EVICEL(TM) Fibrin Sealant (Human) Approved For General Hemostasis In Surgery
ETHICON, INC. announced that the U.S. Food and Drug Administration has granted an expanded indication for EVICEL(TM) Fibrin Sealant (Human). The product is the first fibrin sealant to be indicated as an adjunct to hemostasis for use in patients undergoing surgery, when control of bleeding by standard surgical techniques is ineffective or impractical. EVICEL(TM) is the only all-human plasma-derived fibrin sealant commercially available in the U.S.
More: continued here